Empagliflozin
-
Catalog number2877-10
-
PricePlease ask
-
Size10 mg
-
-
Alternative_name(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol; BI-10773
-
DescriptionEmpagliflozin is a potent and selective SGLT-2 (sodium glucose co-transporter-2) inhibitor (IC₅₀ of 3.1 nM); displays >300-fold selectivity over SGLT-1, 4, 5 and 6. Antidiabetic agent.
-
CAS Number864070-44-0
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₃H₂₇ClO₇
-
Molecular Weight450.91
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>100 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent and selective SGLT-2 (sodium glucose co-transporter-2) inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD22566222
-
PubChem CID11949646
-
SMILESC1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl
-
InChiInChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1
-
InChi KeyOBWASQILIWPZMG-QZMOQZSNSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameEmpagliflozin
-
Alternative nameEmpagliflozin
-